Search research articles
Contact Us
Filters
Showing results (31-40 of 531) with videos related to
Page
of 54
Sort By:
American Journal of Hospital Pharmacy
|
June 1, 1979
Incorrect or unsubstantiated indications listed for selected antimicrobials in the Physicians' Desk Reference
M J Rybak, R Gleckman
Antimicrobial Agents and Chemotherapy
|
May 23, 2003
Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model
Raymond Cha, Michael J Rybak
Antimicrobial Agents and Chemotherapy
|
March 21, 2018
β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA
Nikki Tran, Michael J Rybak
Pharmacotherapy
|
April 29, 2009
Ceftobiprole: first cephalosporin with activity against methicillin-resistant Staphylococcus aureus
Céline Vidaillac, Michael J Rybak
Drug Intelligence & Clinical Pharmacy
|
June 1, 1986
Combination imipenem-aminoglycoside therapy
L M Albrecht, M J Rybak
Drug Intelligence & Clinical Pharmacy
|
July 1, 1983
Subminimum inhibitory concentrations of antimicrobials
S A Hunt, M J Rybak
Antimicrobial Agents and Chemotherapy
|
December 1, 1995
Comparative in vitro activities of LY191145, a new glycopeptide, and vancomycin against Staphylococcus aureus and Staphylococcus-infected fibrin clots
S L Kang, M J Rybak
Drugs
|
September 1, 1996
Combination antimicrobial therapy for bacterial infections. Guidelines for the clinician
M J Rybak, B J McGrath
Pharmacotherapy
|
January 27, 2004
Daptomycin
Kerry L Tedesco, Michael J Rybak
The Annals of Pharmacotherapy
|
June 1, 1994
Single daily dosing of aminoglycosides: a commentary
J C Rotschafer, M J Rybak
Page
of 54
Search research articles
Search
Showing results (31-40 of 531) with videos related to
Sort By:
Page
of 54
American Journal of Hospital Pharmacy
|
June 1, 1979
Incorrect or unsubstantiated indications listed for selected antimicrobials in the Physicians' Desk Reference
M J Rybak, R Gleckman
Antimicrobial Agents and Chemotherapy
|
May 23, 2003
Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model
Raymond Cha, Michael J Rybak
Antimicrobial Agents and Chemotherapy
|
March 21, 2018
β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA
Nikki Tran, Michael J Rybak
Pharmacotherapy
|
April 29, 2009
Ceftobiprole: first cephalosporin with activity against methicillin-resistant Staphylococcus aureus
Céline Vidaillac, Michael J Rybak
Drug Intelligence & Clinical Pharmacy
|
June 1, 1986
Combination imipenem-aminoglycoside therapy
L M Albrecht, M J Rybak
Drug Intelligence & Clinical Pharmacy
|
July 1, 1983
Subminimum inhibitory concentrations of antimicrobials
S A Hunt, M J Rybak
Antimicrobial Agents and Chemotherapy
|
December 1, 1995
Comparative in vitro activities of LY191145, a new glycopeptide, and vancomycin against Staphylococcus aureus and Staphylococcus-infected fibrin clots
S L Kang, M J Rybak
Drugs
|
September 1, 1996
Combination antimicrobial therapy for bacterial infections. Guidelines for the clinician
M J Rybak, B J McGrath
Pharmacotherapy
|
January 27, 2004
Daptomycin
Kerry L Tedesco, Michael J Rybak
The Annals of Pharmacotherapy
|
June 1, 1994
Single daily dosing of aminoglycosides: a commentary
J C Rotschafer, M J Rybak
Page
of 54